The highly expressed cell adhesion receptor CD29 (b 1 -integrin) is essential for cardiomyocyte growth and survival, and its loss of function causes severe heart disease. However, CD29-induced signalling in cardiomyocytes is ill defined and may involve reactive oxygen species (ROS). A decisive source of cardiac ROS is the abundant NADPH oxidase (NOX) isoform NOX2. Because understanding of NOX-derived ROS in the heart is still poor, we sought to test the role of ROS and NOX in CD29-induced survival signalling in cardiomyocytes.
Introduction
Connections to extracellular matrix (ECM) components are essential for the survival and the structural and functional integrity of cardiomyocytes. 1, 2 In particular, transmembrane cell surface adhesion receptors (e.g. integrins) bind ECM proteins such as laminin, collagen, and fibronectin. 3, 4 Integrins are heterodimeric transmembrane receptors composed of an a-and b-subunit. In total, 18 a-and 8 b-chain isoforms are known, which form 24 distinct receptors that are in a bent conformation in quiescent, and in an extended conformation in activated cells. 5, 6 The b 1 -integrin subunit (CD29) represents the most abundant b-isoform expressed in cardiomyocytes, where it can dimerize with different a-subunits. 7 -9 In vitro, CD29 is directly activated by the binding of ECM components or activating antibodies, 10, 11 which causes the rearrangement of the actin cytoskeleton and recruitment of signalling kinases (e.g. mitogen-activated protein kinases) to the cytosolic part of the integrin receptor 4, 12 . Through activation of such signalling kinases, CD29 participates in the regulation of cardiomyocyte growth and survival. Specifically, CD29 facilitates a-adrenergic receptor (AR)-stimulated hypertrophy 13 and inhibits b-AR-induced apoptosis in vitro. 14, 15 In vivo, deletion of CD29 is embryonically lethal, 2, 16 and cardiac-specific disruption or knock-out leads to disturbed cardiac function, impaired cardiac differentiation, fibrosis, and heart failure. 16 -18 Similarly, mouse hearts deficient in CD29 exhibit increased cardiac myocyte apoptosis in response to b-AR stimulation 19 and after myocardial infarction 20 when compared with wild-type (wt) hearts. Furthermore, integrin shedding, which is essential in cardiomyocyte growth, as well as the induction of apoptotic processes referred to as anoikis are typical features associated with the cellular detachment from ECM components. 21 Similarly, cell adhesion of a 5 b 1 -integrin to fibronectin protects against apoptosis in modified Chinese hamster ovary cells expressing a 5 b 1 -integrin. 22 These studies clearly point out the importance of CD29 in cardiomyocyte survival, but the understanding of the likely signalling pathways involved is poor. Several studies affirmed the production of reactive oxygen species (ROS; oxidative burst) by various stimuli, including growth factors or G protein-coupled receptor agonists as well as by cell adhesion as seen in anchorage-dependent cell growth. 23 -26 These ROS act as essential mediators in redox-signalling activating signalling kinases implicated in cell growth, adhesion, and survival. They derive from various oxidase enzymes, including lipoxygenase, xanthine oxidase, or NADPH oxidase (NOX), the latter of which is one of the major sources of cardiac ROS. is further reduced to hydrogen peroxide (H 2 O 2 ), a reaction that occurs either spontaneously or is catalysed by superoxide dismutase (SOD), and finally degraded into water by catalase (cat).
Due to the emerging role of ROS as regulators of cell survival, the crucial role of NOX as a potent source of ROS in the heart and the limited understanding of NOX-derived ROS in cardiomyocytes, we addressed the question if CD29-induced pro-survival signalling depends on NOX-derived ROS in neonatal cardiomyocytes.
Methods
Detailed information on materials and methods is given in the Supplementary material online.
Animal material
Wistar rats (2007 -2010) were obtained from Harlan Laboratories and mice from the Jackson Laboratory. From January 2011, Sprague -Dawley rats originating from in-house breeding were used. All animal protocols were approved by the Veterinary Department of Basel (Switzerland) and conformed to the rules of the Swiss Federal Act on Animal Protection and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Neonatal rat ventricular myocytes (NRVMs) were isolated from the hearts of 1-to 3-day-old pups sacrificed by decapitation and isolation was performed as previously described. 32 
Lucigenin assay
NOX activity was measured using lucigenin-enhanced chemiluminescence. H9c2 cells were treated with a-CD29 antibody or IgG (10 mg/mL, 15 min), then washed three times with cold PBS and scraped into Jude Krebs buffer (see Supplementary material online) containing protease inhibitor cocktail (Roche). Lysates were sonicated (3 s, four times on ice) and centrifuged at 3000 rpm at 48C for 4 min. Measurements of NOX activity were performed by a luminescence assay in a microplate luminometer using 40 mg of lysate with 5 ml DMSO, 10 mmol/L Lucigenin (Sigma), 100 mmol/L NAD(P)H (Sigma), and 50 mmol/L Tiron (Fluka) per well (96-well plate). Data were recorded as relative light units over time, and integrated and calculated as area under the curve using Image J software for statistical analysis.
RNA interference
NRVMs were transfected with 2 mg/10 6 cells ON-TARGETplus using the Amaxa Neonatal Rat Cardiomyocytes Nucleofector kit (VPE-1002), according to the manufacturer's instructions, and efficiency of knockdown was assessed using quantitative RT -PCR.
Cell viability
Cell viability was measured by a tetrazolium (MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)-based colorimetric assay using Cell Proliferation Kit I (Roche) according to the manufacturer's instructions.
Statistical analyses
All statistical analyses were performed in Graphpad Prism version 4.03 and P-values ,0.05 were considered to indicate significant differences. Significance was tested in repeated measures one-way ANOVA with Bonferroni's post-test (for sample sizes less than or equal to four) or Newman -Keuls (for more than four samples to compare) correction.
NOX2 mediates CD29-induced survival signalling
For analysing flow cytometry data, the geometric mean was used and overlays were performed in FloJo software version 7.5.5. (Tri Star Inc.).
Results

CD29 activation induces a time-dependent oxidative burst, which is impaired by apocynin and diphenylene iodonium in cardiomyocytes
To assess whether CD29 activation generates ROS in NRVM, the redox-sensitive fluorescent dye 5-(and-6)-chloromethyl-2 ′ ,7 ′ -dichlorodihydrofluorescein diacetate acetyl ester (DCF) was used. Flow cytometry analyses demonstrated a significant increase in DCF fluorescence indicative of an oxidative burst after 30 min of incubation of NRVM with an activating a-CD29 antibody, which subsided after 2 h ( Figure 1A and B) . A qualitatively similar increase in DCF fluorescence was observed in response to exogenous ROS (H 2 O 2 , 100 mmol/L) and to 12-phorbol 13-myristate acetate (PMA, 1 mmol/L), which induces endogenous ROS in other cell types 40, 41 ( Figure 1A) . We further investigated the NOX-dependency of this burst using the inhibitors apocynin (apo, 500 mmol/L) and diphenylene iodonium (DPI, 10 mmol/L). Apocynin is, besides known to inhibit the regulatory NOX subunit p47 phox in leukocytes, implicated as an antioxidant in endothelial and smooth muscle cells, 42 and DPI inhibits flavoenzymes, including NOX. 43 Both compounds markedly decreased DCF fluorescence intensity when administered prior to a-CD29 ( Figure 1C -E).
CD29 activation induces NOX activity in cardiomyocytes
As both apocynin and DPI are non-specific, H9c2 cardiomyoblasts were treated with a-CD29 or non-immune IgG (10 mg/mL, 15 min) and NOX activity was measured by lucigenin-enhanced chemiluminescence. Cross-linkage of CD29 via activating antibody significantly enhanced NADPH-dependent lucigenin chemiluminescence in H9c2 cells (Figure 2A and B) , thus confirming activation of NOX in response to CD29 stimulation. A similar observation was made in NRVM plated on dishes precoated with laminin, the physiological ligand for CD29. These cells exhibited higher NOX activity when compared with NRVM plated on non-coated dishes (data not shown).
3.3 CD29 activation induces phosphorylation of ERK1/2 (Thr202/ Tyr204), Akt (Ser473), and GSK-3b (Ser9) CD29 activates the MEK/ERK and the PI3K/Akt pathways in various cell types. 12 In NRVM, increased phosphorylation of ERK and Akt was observed upon CD29 stimulation, which peaked at 15 min and was no longer detectable at 45 min (Supplementary material online, Figure S1A and B). Phosphorylation of serine 9 of glycogen synthase kinase (GSK)-3b, which is inhibitory to its kinase activity, was used to measure CD29-induced pro-survival signalling, because (i) it is involved in the CD29-induced anti-apoptotic effect in adult cardiomyocytes 44 and (ii) it is downstream of the PI3K/Akt pathway. 45 Using a phosphorylation site-specific GSK-3b (Ser9) antibody, immunoreactive bands were observed at 15 min (Supplementary material online, Figure S1C ). No changes in phosphorylation were detectable when cardiomyocytes were incubated with either an inhibitory a-CD29 antibody or with a non-specific IgG (Supplementary material online, Figure S1A -C). 
CD29-induced pro-survival signalling is ROS-dependent
Because activation of CD29 induced an oxidative burst in cardiomyocytes (Figure 1) , the possibility exists that CD29-stimulated signalling is ROS-regulated. To test this hypothesis, MnTMPyP (MnT), a mimetic of the antioxidant enzymes SOD and cat, was used to reduce ROS levels. Pretreatment with MnT significantly inhibited the a-CD29-induced phosphorylation of ERK1/2 (Supplementary material online, Figure S3A ), Akt (Supplementary material online, Figure S3B) , and GSK-3b (Supplementary material online, Figure S3C) . Similarly, co-overexpression of SOD and cat using adenoviral constructs significantly reduced MEK-, Akt-, and GSK-3b-phosphorylation ( Figure 3A-C ) . To assess the respective contribution of O 2 †2 and H 2 O 2 to CD29-induced signalling, similar experiments were performed in NRVM expressing either SOD or cat. Although either enzyme inhibited phospho-MEK1/2 and phospho-GSK-3b, persistence of phospho-Akt was observed with overexpression of SOD, but not of cat, up to 100 MOI ( Figure 3D and Supplementary material online, Figure S4 ).
CD29-induced pro-survival signalling is inhibited by apocynin and DPI
Primarily, a likely role of NOX in CD29-induced survival signalling was investigated using apo and DPI. Both inhibitors suppressed CD29-induced ERK1/2-(Supplementary material online, Figure S5A and D) and Akt-phosphorylation (Supplementary material online, Figure S5B and E). Although both apo and DPI also inhibited the CD29-induced GSK-3b phosphorylation, the reliable assessment of this inhibition is hindered, because both substances affected basal kinase phosphorylation (Supplementary material online, Figure S5C and F). However, these findings suggest that NOX might serve as the source of CD29-induced ROS that trigger ROS-dependent prosurvival signalling in cardiomyocytes.
3.6 gp91 phox -and p47 phox -deficient cardiomyocytes show loss of a-CD29-induced pro-survival signals
In another set of experiments, NOX was corroborated as source of ROS by examining a-CD29-induced signalling in NMVMs isolated from gp91 phox (NOX2) knock-out mice and from mice lacking a functional catalytic subunit p47 phox . Upon CD29 stimulation, significantly lower levels of phospho-ERK1/2, phospho-Akt, and phospho-GSK-3b were observed in NOX2-knock-out mouse cardiomyocytes when compared with wt ( Figure 4A-C) . In p47 phox LOF NMVM, CD29 activation failed to induce phosphorylation of Akt (Ser473; Figure 4E ) and GSK-3b (Ser9; Figure 4F ). In contrast, CD29-induced phosphorylation of ERK1/2 ( Figure 4D ) was unaffected by the loss of functional 3.7 The CD29-induced oxidative burst is impaired in p47 phox -LOF, but not in NOX2-knock-out cardiomyocytes Because NOX2-derived ROS play an important role in CD29-induced pro-survival signalling in NMVM, we tested whether the CD29-induced oxidative burst was impaired in NMVM deficient in NOX2 or p47 phox . Upon activation of CD29, a shift in DCF fluorescence was observed in wt NMVM that was missing in p47 phox -LOF NMVM ( Figure 5A and C ) . In contrast, in NOX2-knock-out cells, CD29 activation enhanced DCF fluorescence ( Figure 5B and D) .
Therefore, another p47 phox -dependent NOX (e.g. NOX1) 46 might be involved in CD29-induced ROS formation in NMVM.
Discussion
This work demonstrates that NOX-derived ROS regulate cardiomyocyte survival pathways. Similar to what has been described for growth factors and cytokines, 29 transient endogenous ROS were formed in cardiomyocytes in response to CD29 activation ( Figure 6 ) and this ROS formation was impaired by NOX inhibitors. These findings are in agreement with DPI-based data implicating NOX in CD29-induced ROS production in the colic adenocarcinoma cell line (caco-2), 47 but not with findings from mouse embryonic fibroblasts (NIH-3T3), where synergistically growth factor-and integrin-driven ROS were mostly lipoxygenase-dependent. 48 In cardiac myocytes, however, Figure 3 CD29-induced pro-survival signalling depends on ROS. (A -C) NRVM were infected with adenoviral constructs to express b-galactosidase (LacZ 100 ) at 100 MOI or co-overexpress SOD (S 50 ) and cat (C 50 ) at 50 MOI 36 h prior to a-CD29 administration (10 mg/mL, 15 min). Equal protein amounts were subjected to western blotting using phosphorylation-specific antibodies for MEK1/2 (Ser217/221), Akt (Ser473), and GSK-3b (Ser9). Data are presented as mean + SEM. *** and ### P , 0.001, ** and ## P , 0.01, and # P , 0.05 (n ¼ 5 for A and B, n ¼ 3 for C). Unless indicated otherwise, comparisons were not significant. (D) Western blot of CD29-induced signalling with single-enzyme overexpression at two different MOI, including the protein expressions of SOD and cat.
CD29 activation induced NOX activity and an additional line of evidence for NOX-involvement was obtained using gene knock-outs (see below).
ROS at moderate levels may serve as signalling molecules participating in the regulation of cell survival, 24, 49, 50 because of their ability to activate pro-survival related cascades, including the PI3K/Akt and the MEK/ERK pathway. 51 A prominent target of Akt is GSK3, 52 of which two isoforms, GSK-3a and GSK-3b, are expressed in cardiomyocytes. Inhibition of GSK-3 via the PI3K pathway promotes cell survival in Drosophila or neurones. 53 Additionally, CD29-dependent, PI3K-mediated phosphorylation of the inhibitory GSK-3b Ser9 protects adult rat cardiomyocytes from b-AR-induced apoptosis.
44
Although GSK-3b is reportedly directly phosphorylated by Akt, several other kinases, including the ERK1/2 target p90 ribosomal S6 kinase have also been implicated in GSK-3b inhibition in the heart. 45 Our data show activation of both, the PI3K/Akt and the MEK/ERK pathway upon CD29 engagement in NRVM and uncover GSK-3b as a target of both these pathways. Clearance of ROS by antioxidants elicited apoptotic pathways in leukaemia cells, inhibiting the phosphorylation of Akt or ERK. 54 In accordance with these findings, co-overexpression of both SOD and catalase ( Figure 3 ) significantly diminished CD29-induced phosphorylation of MEK1/2, Akt, and GSK-3b. It is of note that at higher expression levels single-enzyme overexpression was equally effective with regard to induced phospho-MEK/ERK and -GSK-3b inhibition, implicating both O †− 2 and H 2 O 2 as second messengers in CD29-induced pro-survival signal transduction in NRVM. However, SOD appeared less efficient to suppress Akt-phosphorylation than catalase. Although this difference could be attributed to the lower expression levels of SOD, differential regulation of the PI3K/Akt pathway through O †− 2 and H 2 O 2 cannot be ruled out. DPI and apocynin inhibited the CD29-induced phosphorylation of ERK1/2, Akt, and GSK-3b, implying NOX-derived ROS as signalling mediators. Mice carrying either a knock-out of the transmembrane NADPH oxidase subunit NOX2, or a LOF from the regulatory subunit p47 phox were used to assess whether NOX2 is required for CD29-induced survival signalling in NMVM. Indeed, NOX2 knock-out NMVM showed reduced levels of CD29-induced ERK1/2 phosphorylation and the CD29-inducible phosphorylation of Akt and GSK-3b were nearly abolished in both NOX2 knock-out and p47 phox -LOF cardiomyocytes ( Figure 4A-F ) , highlighting the central role of NOX2-and p47 phox -derived ROS in CD29-induced survival signalling.
In contrast to NOX2 knock-out cardiomyocytes, however, where CD29-induced ERK-phosphorylation was mostly suppressed, NOX2 mediates CD29-induced survival signalling induced phospho-ERK was still solid in p47 phox -LOF cardiomyocytes.
Although no oxidative burst was detectable in p47 phox -LOF cardiomyocytes at 15 min, i.e. at the time of peak signalling, a compensatory pathway involving weaker, NOXO1-supported ROS release may account for ERK activation in the absence of functional p47 phox . Alternatively, lack of ROS may allow for a ROS-independent pathway to activate ERK. In fact, co-existence of ROS-dependent and -independent pathways namely regarding ERK activation has previously been observed in other cell types. 55, 56 Interestingly, whereas the CD29-induced oxidative burst was absent in p47 phox -LOF, it was maintained in NOX2 knock-out cardiomyocytes ( Figure 5 ). Because both NOX1 and NOX2 may use p47 phox to generate ROS in a stimulus-dependent manner, 46 preservation of the oxidative burst in the absence of NOX2 implies another functional NOX homologue (for example NOX1) as an additional and/or compensatory ROS source. However, these additional ROS are unlikely to be involved in CD29-induced survival signalling, because this signalling is lacking in NOX2 knock-out mice. It is noteworthy that reciprocal compensation of NOX2 and NOX4 has been observed in human lung endothelial cells. 57 Furthermore, there is evidence for spatiotemporal-defined localization of NOX isoforms at the plasma membrane (NOX2) or in subcellular compartments (e.g. endosomes, NOX1 and NOX2) 58, 59 and different NOX isoforms may elicit distinct signalling. 60 Importantly, NOX2-derived ROS have been implicated as mediators of cardiomyocyte protection against ischaemia/reperfusion injury conferred by ischaemic preconditioning. 61 These findings point out the importance of NOX-derived ROS and are in accordance with our findings that NOX2-derived ROS act as mediators of pro-survival signalling in cardiomyocytes. In fact, CD29 activation improved survival of NOX2-competent cardiomyocytes exposed to oxidative stress (H 2 O 2 ), but appeared not to do so in NOX2-deficient cells (Supplementary material online, Figure S6 ). A proposed model for the role of NOX2-derived ROS in CD29-induced pro-survival signalling in cardiomyocytes is depicted in Figure 6 .
In conclusion, CD29-induced pro-survival signalling in cardiomyocytes is ROS-dependent and NOX2 acts as source of these ROS. Moreover, CD29-induced inhibition of the pro-apoptotic kinase GSK-3b depends upon NOX2-derived ROS in rat and mouse cardiomyocytes. These findings support a beneficial role for NOX2-derived ROS in cell survival in the heart.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
